Compare Stocks → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:PPHNASDAQ:REAL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePPHVanEck Pharmaceutical ETF$86.52+0.2%$88.73$74.05▼$91.16$496.63M0.72126,620 shs347,614 shsREALRealReal$3.40-1.4%$3.11$1.00▼$4.10$360.23M2.993.31 million shs1.08 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePPHVanEck Pharmaceutical ETF-0.63%+1.39%-3.74%+2.44%+8.59%REALRealReal0.00%+9.18%-1.43%+74.24%+222.43%The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AREALRealReal0.4479 of 5 stars1.22.00.00.01.93.30.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePPHVanEck Pharmaceutical ETF0.00N/A$95.5710.46% UpsideREALRealReal2.33Hold$3.616.30% UpsideCurrent Analyst RatingsLatest IHP, PPH, REAL, RIB, and PRSM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/12/2024REALRealRealUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.30 ➝ $3.703/1/2024REALRealRealNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AREALRealReal$549.30M0.66N/AN/A($2.97) per share-1.14Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePPHVanEck Pharmaceutical ETFN/AN/A20.57∞N/AN/AN/AN/AN/AREALRealReal-$168.47M-$1.67N/AN/AN/A-30.67%N/A-26.38%5/7/2024 (Confirmed)Latest IHP, PPH, REAL, RIB, and PRSM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2024N/AREALRealReal-$0.14N/A+$0.14N/AN/AN/A 2/29/2024Q4 2023REALRealReal-$0.19-$0.15+$0.04-$0.09$142.80 million$143.37 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPPHVanEck Pharmaceutical ETF$1.561.80%N/AN/AN/AREALRealRealN/AN/AN/AN/AN/ALatest IHP, PPH, REAL, RIB, and PRSM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2024PPHVanEck Pharmaceutical ETF$0.53284/1/20244/2/20244/5/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPPHVanEck Pharmaceutical ETFN/AN/AN/AREALRealRealN/A1.251.13OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPPHVanEck Pharmaceutical ETFN/AREALRealReal64.73%Insider OwnershipCompanyInsider OwnershipPPHVanEck Pharmaceutical ETFN/AREALRealReal9.34%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionablePPHVanEck Pharmaceutical ETF147,0005.74 millionN/AOptionableREALRealReal3,032105.95 million96.05 millionNot OptionableIHP, PPH, REAL, RIB, and PRSM HeadlinesSourceHeadlineRealReal (NASDAQ:REAL) and Lavoro (NASDAQ:LVRO) Head to Head Surveyamericanbankingnews.com - April 24 at 2:04 AMThe RealReal Launches Retail Initiative to Benefit Conservation Internationalglobenewswire.com - April 22 at 4:09 PMTikTok Shop Launches Secondhand Luxury Fashion Category in UKtechtimes.com - April 22 at 1:34 AMInvest like the rich: These luxury items gain value over timefinance.yahoo.com - April 20 at 12:20 PMThe RealReal Stock: Turnaround Strategy Faces A Big Test In 2024seekingalpha.com - April 19 at 7:48 AMThe RealReal, Inc. (NASDAQ:REAL) Receives $3.61 Average PT from Brokeragesamericanbankingnews.com - April 15 at 1:12 AMThe RealReal, Inc. (NASDAQ:REAL) Given Consensus Recommendation of "Hold" by Analystsmarketbeat.com - April 12 at 10:27 AMUBS Group Boosts RealReal (NASDAQ:REAL) Price Target to $3.70marketbeat.com - April 12 at 8:27 AMThe RealReal Announces Timing of Its First Quarter 2024 Earnings Conference Callglobenewswire.com - April 11 at 4:12 PMWhere To Get Rid of Your Old Stuffmsn.com - April 8 at 8:03 PMHow To Mix High and Low Pieces Into Your Wardrobemsn.com - April 5 at 12:27 AMLouis Vuitton Totes and Dior Micro Bags Can Save Luxurybloomberg.com - April 5 at 12:27 AMMan connected to two Worth Avenue jewelry store smash-and-grabs is charged in a thirdpalmbeachpost.com - April 5 at 12:27 AMDominic Burgess Talks ‘Palm Royale,’ His Sex Scene With Kim Kardashian on ‘AHS’ and How a Failed ‘iCarly’ Audition Led to His Big Breakyahoo.com - April 5 at 12:27 AMWhat is the Best Site to Sell Clothes on: Top 5 Optionsalbawaba.com - April 3 at 5:40 PMWhat Happened to the Wrap Dress?nytimes.com - April 2 at 4:38 PMThe RealReal, Inc. (NASDAQ:REAL) Sees Significant Increase in Short Interestmarketbeat.com - April 1 at 8:31 AMThe History Behind the Iconic Hermès Kelly Bagmsn.com - April 1 at 4:36 AMSix Ways to Wear Brown, Inspired by the Runwayswmagazine.com - March 29 at 5:04 PMThredUp Releases Resale State of the Unionuk.movies.yahoo.com - March 28 at 1:32 PMThe RealReal, Inc.: The RealReal Earnings: Restructuring Lessens Risk of Debt Default or a Dilutive Equity Raisefinance.yahoo.com - March 28 at 3:31 AMMercari drops seller feesaxios.com - March 27 at 10:31 PMThe Global Secondhand Market Grew Faster Than Traditional Retail Last Year, According to ThredUp’s Annual Reportyahoo.com - March 27 at 12:31 PMThese are the best-performing ‘Big Short” Michael Burry stocks of 2024finbold.com - March 26 at 9:09 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Energy Plays for Cash Flow: Buy 1 or Buy Them AllApril 15, 2024 10:16 AMView 3 Energy Plays for Cash Flow: Buy 1 or Buy Them AllDocuSign and The Case for 66% Upside April 16, 2024 10:20 AMView DocuSign and The Case for 66% Upside How to Use an Options Call Butterfly for Rangebound Stocks April 4, 2024 7:57 AMView How to Use an Options Call Butterfly for Rangebound Stocks Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?April 16, 2024 6:15 AMView Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?Prologis Stock Leading U.S. Logistics BoomApril 17, 2024 7:50 AMView Prologis Stock Leading U.S. Logistics BoomAll Headlines Company DescriptionsVanEck Pharmaceutical ETFNASDAQ:PPHThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.RealRealNASDAQ:REALThe RealReal, Inc. operates an online marketplace for resale luxury goods in the United State. The company offers various product categories, including women's fashion, men's fashion, jewelry, and watches. It primarily sells products through online marketplace and retail stores. The company was incorporated in 2011 and is headquartered in San Francisco, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.